BNP Paribas Financial Markets
CAI

BNP Paribas Financial Markets’s Caris Life Sciences CAI Stock Holding History

BNP Paribas Financial Markets’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Buy
1,614,286
+928,460
+135% +$20.3M 0.01% 947
2025
Q4 		$18.5M Buy
685,826
+684,626
+57,052% +$19.3M 0.01% 1231
2025
Q3 		$36.3K Buy
+1,200
New +$38.3K ﹤0.01% 4727

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

BNP Paribas Financial Markets's CAI Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Caris Life Sciences (CAI) stake by 135% in Q1 2026, buying an estimated $20.3M and bringing the position to 1,614,286 shares worth $28.9M. The position accounts for 0.01% of the portfolio, ranked #947.

BNP Paribas Financial Markets first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • BNP Paribas Financial Markets held 1,614,286 shares of Caris Life Sciences worth $28.9M as of Q1 2026.
  • BNP Paribas Financial Markets bought 928,460 Caris Life Sciences shares in Q1 2026, an estimated $20.3M.
  • Caris Life Sciences made up 0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #947 holding.
  • BNP Paribas Financial Markets first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.